Pfizer begins human testing for experimental coronavirus vaccine in the US
May 05, 2020 at 06:45 AM EDT
The U.S.-based company, which is working alongside German drugmaker BioNTech, said the first human participants in the United States have been dosed with the potential vaccine, BNT162.